drugset / Trial / NCT02211625
A Safety, Tolerability, PD and PK Study in Healthy Adults
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of TRV734 given as a single dose (Part A) and as multiple ascending doses (Part B) in healthy subjects.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oxycodone | Other / unclassified | 10 mg | — |
| Subject | TRV734 | Unknown | 125 mg | — |
Indications
No indication recorded.